DBV Technologies S.A. (NASDAQ:DBVT) changes shares on Wednesday trading session, with a change of 5.98% or $0.14 shares. The trading starts at $2.49 and closed at $2.34 throughout the day. The trading session low price was $2.45 and day high was $2.50 on Wednesday, August 05. After the session, the Healthcare sector daily volume shifted to 2.23 million while its average volume is 309.64K. In other hand, the DBVT market cap reached to $272.16M.
On August 4, 2020, U.S. FDA declines to approve DBV Technologies’ peanut allergy patch. According to the news reported on Reuters, French drug developer DBV Technologies SA said on Tuesday the U.S. health regulator declined to approve its experimental skin patch for peanut allergy in children, citing concerns about its effectiveness.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -38.46% and down -45.73% for month. Its quarterly performance was -56.34% below, while its half year performance is down -75.15%. DBVT yearly performance stood at negative -72.29% and fall -76.82% for year-to-date. Current recommendation for DBV Technologies S.A. is 2.30.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. DBVT EPS (TTM) for 12-month is -3.27. EPS for this year is -19.50%, while for the next year its value is -2.12. It has an EPS of next five years will be up 37.90%.
Let’s take a look on the analyst recommendations on DBVT for the current month and previous month. For the current month, 8 of 13 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 1 as underweight and 4 as Hold. As compared with the previous month ratings, 11 analysts participate in stock recommendation. Out of 11, 0 rated it sell, 6 rated it as Buy and 4 as Hold Ratings. On the other hand, target price ranges from $1.68 – $15.35. Average target price for DBVT was reached at $6.79.
The institutional holding shifted to 49.15%.
The company posted an EPS (TTM) of -3.27. According to the most recent quarter report on Name, DBV Technologies S.A. analysts estimated an average EPS of Invesco DB G10 Currency Harvest, while MBVT EPS posted a year ago period. Analyst Estimated EPS for DBVT published in the report was $VIABUILT VENTURES INC – $DBV TECHNOLOGIES during the same period.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for DBVT fall -64.32% for period of 200 days. SMA for 50 days was -47.75% which is showing red signal, while SMA-20 was -40.79%.